2-Phenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazole, 97%, 250mg

Ethyl 2-amino-6-phenyl-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate, 97%, 50mg

3-(4-FLUOROPHENYL)-3-HYDROXYPROPANENITRILE, 95%, 2.5g

4-Bromo-2-fluoro-3-methylbenzoic acid, 95.0%, 5g

Fmoc-Lys(N3)-OH, 95.0%, 10g

4-Bromo-3-formyl-1H-indazole-6-carboxylic acid, 95.0%, 250mg

2-Bromotetrafluoroethyl trifluorovinyl ether, 97.0%, 25g

Tert-butyl 4-(3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)piperazine-1-carboxylate, 96%, 250mg

(2E)-1-(2,4-dimethylphenyl)-3-(thiophen-2-yl)prop-2-en-1-one, 95.0%, 2g

3-(3,4-Difluorophenyl)propan-1-amine hydrochloride, 50mg

4-Methylcyclohexanecarboxylic Acid (cis- and trans- mixture)>98.0%(GC)(T)5g

Sodium L-Glutamate Monohydrate>99.0%(T)25g

(R)-2-((tert-Butoxycarbonyl)amino)-5-(cyclohexyloxy)-5-oxopentanoic acid, 95.0%, 100g